Turnstone Biologics's common stock is $23K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Turnstone Biologics (TSBX) currently reports a common stock of $23K as of June 2025. That compares with $23K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Turnstone Biologics's common stock history and peer comparisons.
Turnstone Biologics's common stock was unchanged from $23K to $23K — essentially flat versus a year earlier (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Turnstone Biologics reported $23K in common stock as of June 2025. That compares with $23K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $23K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Turnstone Biologics, and consider following TSBX for alerts when major investors trade the stock.